We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Polivy Chemo Cocktail Boosts Progression-Free Survival in B-cell Lymphoma
Polivy Chemo Cocktail Boosts Progression-Free Survival in B-cell Lymphoma
A multidrug chemotherapy cocktail featuring Polivy (polatuzumab vedotin) has scored high as a first-line therapy for patients with diffuse large B-cell lymphoma, (DLBCL), according to preliminary information released by Roche subsidiary Genentech.